Literature DB >> 311589

Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases.

G S Pinkus, J W Said.   

Abstract

Tissues from 72 cases (87 specimens) of various non-Hodgkin's lymphomas were analyzed for cell markers using multiple techniques. Cell suspensions were evaluated for E, EAC, and IgGEA rosette forming cells; Fc receptor cells; and surface immunoglobulin bearing cells. Cryostat section studies topographically defined EAC binding cells. Cytochemical determinations and immunoperoxidase methods for detection of intracellular immunoglobulin and lysozyme complemented other techniques in evaluating infiltrates containing large neoplastic cells. B-cell malignancies comprised 58 cases (80%) of this series and included well and moderately well differentiated lymphocytic lymphomas (10/10); nodular (23/23) and diffuse (10/18) poorly differentiated lymphocytic lymphomas; and lymphomas of mixed lymphocytic-"histiocytic" (3/3), "undifferentiated" (3/3), and "histiocytic" (9/13) types. Nodular lymphomas were characterized as B-cell neoplasms but also revealed a prominent population of T lymphocytes (39 +/- 12%). Alkaline phosphatase activity, a cytochemical marker for lymphoid cells of follicular cuffs, was most consistently observed in B-cell lymphomas of moderately well differentiated lymphocytic type (4/6 cases). In some diffuse lymphomas, cryostat section studies (EAC rosettes) suggested a pre-existing nodular proliferation. One unusual B-cell lymphoma of large cell type exhibited IgGEA rosette formation and a strong receptor for the Fc portion of IgG. Ten lymphomas (14%) were of T-cell type and were represented by cases of diffuse poorly differentiated lymphocytic lymphoma (5/18, including 3 lymphoblastic lymphomas), Sézary syndrome (1), mycosis fungoides (1), and a cytologically distinctive large cell ("histiocytic") lymphoma (3/13). Acid phosphatase activity was a consistent marker for the T-cell malignancies, some of which also revealed alpha-naphthyl butyrate esterase activity. No true histiocytic lymphomas were detected. Three cases of diffuse poorly differentiated lymphocytic lymphoma and one "histiocytic" lymphoma were null.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 311589      PMCID: PMC2042240     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  67 in total

1.  UPTAKE OF DYES AND DRUGS BY LIVING CELLS IN CULTURE.

Authors:  A C ALLISON; M R YOUNG
Journal:  Life Sci (1962)       Date:  1964-12

2.  Acid phosphatase activity in human blood cells.

Authors:  A F GOLDBERG; T BARKA
Journal:  Nature       Date:  1962-07-21       Impact factor: 49.962

3.  Follicular lymphoma; a re-evaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases.

Authors:  E B HICKS; H RAPPAPORT; W J WINTER
Journal:  Cancer       Date:  1956 Jul-Aug       Impact factor: 6.860

4.  Functional markers: a new perspective on malignant lymphomas.

Authors:  E S Jaffe; R C Braylan; K Nanba; M M Frank; C W Berard
Journal:  Cancer Treat Rep       Date:  1977-09

5.  Alkaline phosphatase-positive malignant lymphoma. A subtype of B-cell lymphomas.

Authors:  K Nanba; E S Jaffe; R C Braylan; E J Soban; C W Berard
Journal:  Am J Clin Pathol       Date:  1977-11       Impact factor: 2.493

6.  Immunologic and cytochemical cell markers in non-Hodgkin's lymphomas.

Authors:  F R Davey; J Goldberg; J Stockman; A J Gottlieb
Journal:  Lab Invest       Date:  1976-11       Impact factor: 5.662

7.  Immunologic surface markers in non-Hodgkin's lymphomas.

Authors:  J Cossman; B Schnitzer; M J Deegan
Journal:  Am J Pathol       Date:  1977-04       Impact factor: 4.307

8.  Specific identification of intracellular immunoglobulin in paraffin sections of multiple myeloma and macroglobulinemia using an immunoperoxidase technique.

Authors:  G S Pinkus; J W Said
Journal:  Am J Pathol       Date:  1977-04       Impact factor: 4.307

9.  T cell leukemia--lymphoma in young adults.

Authors:  M Palutke; D J Patt; R Weise; C Varadachari; R F Wylin; C R Bishop; P M Tabaczka
Journal:  Am J Clin Pathol       Date:  1977-10       Impact factor: 2.493

10.  Malignant lymphoma, lymphoblastic.

Authors:  B N Nathwani; H Kim; H Rappaport
Journal:  Cancer       Date:  1976-08       Impact factor: 6.860

View more
  16 in total

1.  Systemic malignant lymphoma presenting as bilateral exudative retinal detachment.

Authors:  B A Kormann; H Holzgreve; P G Wolff-Kormann; K G Riedel
Journal:  Klin Wochenschr       Date:  1990-10-17

2.  Cell proliferation in non-Hodgkin's lymphomas. Digital image analysis of Ki-67 antibody staining.

Authors:  B R Schwartz; G Pinkus; S Bacus; M Toder; D S Weinberg
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

3.  Leu-M1--a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues.

Authors:  G S Pinkus; P Thomas; J W Said
Journal:  Am J Pathol       Date:  1985-05       Impact factor: 4.307

4.  Malignant lymphomas.

Authors:  B H Tindle
Journal:  Am J Pathol       Date:  1984-07       Impact factor: 4.307

5.  Immunohistologic cellular phenotypes of lymphoproliferative disorders. Comprehensive evaluation of 564 cases including 257 non-Hodgkin's lymphomas classified by the International Working Formulation.

Authors:  R R Tubbs; A Fishleder; R A Weiss; R A Savage; B A Sebek; J K Weick
Journal:  Am J Pathol       Date:  1983-11       Impact factor: 4.307

6.  Studies on blood lymphocytes of patients with nodular poorly differentiated lymphocytic lymphoma.

Authors:  A S Krajewski; A E Dewar
Journal:  J Clin Pathol       Date:  1981-08       Impact factor: 3.411

7.  Quantitative analysis of non-Hodgkin's lymphoma.

Authors:  C R Abbott; R W Blewitt; C C Bird
Journal:  J Clin Pathol       Date:  1982-02       Impact factor: 3.411

8.  alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders.

Authors:  G S Pinkus; H K Hargreaves; J A McLeod; L M Nadler; D S Rosenthal; J W Said
Journal:  Am J Pathol       Date:  1979-10       Impact factor: 4.307

9.  The immunologic characterization of 95 nodal and extranodal diffuse large cell lymphomas in 89 patients.

Authors:  R S Doggett; G S Wood; S Horning; R Levy; R F Dorfman; J Bindl; R A Warnke
Journal:  Am J Pathol       Date:  1984-05       Impact factor: 4.307

10.  Centrocytic lymphoma: a distinct clinicopathologic and immunologic entity. A multiparameter study of 18 cases at diagnosis and relapse.

Authors:  S H Swerdlow; J A Habeshaw; L J Murray; H S Dhaliwal; T A Lister; A G Stansfeld
Journal:  Am J Pathol       Date:  1983-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.